MedTrace Logo

Ozone Autohemotherapy for Ischemic Stroke Sleep Disorder

NCT05508113 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-08-22

No results posted yet for this study

Summary

The purpose of this study is to observe the efficacy and safety of ozonated autohemotherapy in patients of post-ischemic stroke insomnia and to explore its mechanism of action.

Conditions

  • Post-ischemic Stroke Insomnia

Interventions

OTHER

ozone autohemotherapy

After autologous blood is mixed with ozone in vitro, the blood is injected into the patient through intravenous infusion

Sponsors & Collaborators

  • Mengmeng Chen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-26
Primary Completion
2022-12-31
Completion
2022-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05508113 on ClinicalTrials.gov